105346-32-5

Basic information

• Product Name: ethyl 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propionate
• Synonyms: ethyl 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propionate
• CAS NO: 105346-32-5
• Molecular Weight: 276.289
• Mol File: 105346-32-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: ethyl 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propionate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propionate(105346-32-5)
• EPA Substance Registry System: ethyl 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propionate(105346-32-5)

Safety Data

• Hazardous Substances Data: 105346-32-5(Hazardous Substances Data)

Upstream product

• 10138-10-0 ethyl 4-oxobutanoate 
• 6362-58-9 methyl phenylpyruvate 
• 156-06-9 2-oxo-3-(phenyl)propionic acid 

Downstream Products

• 105346-37-0 ethyl 3-(5-oxo-4-pentyloxy-3-phenyl-2,5-dihydro-2-furyl)propionate 
• 105346-60-9 3 (2,5 dihydro 3 hydroxy 2 oxo 4 phenyl 5 furyl)propionic acid 
• 117085-42-4 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propanamide 
• 100475-04-5 3-[4-(3,4-Dichloro-benzyloxy)-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl]-propionic acid 
• 102227-54-3 3-<4-(4-methoxybenzoyloxy)-5-oxo-3-phenyl-2,5-dihydro-2-furyl>propionic acid 
• 100475-05-6 3-(4-Decyloxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)-propionic acid 
• 100475-03-4 3-[4-(4-Chloro-benzyloxy)-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl]-propionic acid 
• 100475-02-3 3-[4-(4-Methyl-benzyloxy)-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl]-propionic acid 
• 100474-98-4 3-(4-Heptyloxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)-propionic acid 
• 100475-01-2 3-(4-Benzyloxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)-propionic acid 
• 105346-44-9 3-(5-oxo-4-pentyloxy-3-phenyl-2,5-dihydro-2-furyl)propionic acid 
• 105346-50-7 3-(4-Butoxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)-propionic acid 
• 105346-49-4 3-(5-Oxo-3-phenyl-4-propoxy-2,5-dihydro-furan-2-yl)-propionic acid 
• 105346-48-3 3-(4-Ethoxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)-propionic acid 

Relevant articles and documents

Pharmaceutical preparation for prevention and/or treatment for cataract

In order to prevent or treat cataract, present invention features 3(2H)-furanone derivatives having 3(2H)-furanone skeleton as a main structure and/or pharmaceutically acceptable salts thereof, pharmaceutical preparations containing the derivatives and/or

An efficient synthesis of WF-3681, a novel aldose reductase inhibitor, and its related compounds

-